Cargando…
Alternatively activated NUSAP1 promotes tumor growth and indicates poor prognosis in hepatocellular carcinoma
BACKGROUND: Hepatocellular carcinoma (HCC) is one of the most common malignancies with high mortality. The key genes involved in initiation and development of HCC is not entirely clear. METHODS: We performed a meta-analysis of available transcriptome data from 6 independent HCC datasets [5 datasets...
Autores principales: | Shi, Chao, Xu, Hui, Liu, Junyu, Zhong, Yuanbin, Zhang, Xinping, Tong, Xiaoqin, Zhang, Lunli, Li, Xiaopeng, Deng, Libin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799080/ https://www.ncbi.nlm.nih.gov/pubmed/35116752 http://dx.doi.org/10.21037/tcr.2019.01.29 |
Ejemplares similares
-
miR-206 inhibits cell proliferation, invasion, and migration by down-regulating PTP1B in hepatocellular carcinoma
por: Yang, Qian, et al.
Publicado: (2019) -
Decreased Expression of NUSAP1 Predicts Poor Overall Survival in Cervical Cancer
por: Xie, Qiqi, et al.
Publicado: (2020) -
MCM2 and NUSAP1 Are Potential Biomarkers for the Diagnosis and Prognosis of Pancreatic Cancer
por: Deng, Yajun, et al.
Publicado: (2020) -
Exploration of the effects of the CYCLOPS gene RBM17 in hepatocellular carcinoma
por: Li, Can, et al.
Publicado: (2020) -
CCNB2, NUSAP1 and TK1 are associated with the prognosis and progression of hepatocellular carcinoma, as revealed by co-expression analysis
por: Liu, Linglong, et al.
Publicado: (2020)